Skip to content

Ardelyx, Inc.

ARDX· NasdaqCore metricsCIK 1437402

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -0.48%
Market cap
$781.77M
251.37M shares
Filings
1,032
$127.66M
Q3 2026+22.1% FY25 yoy
-$737.00K
Q3 2026N/M FY25 yoy
$4.02M
Q3 2026N/M FY25 yoy
-$36.55M
Q3 2026derivedN/M FY25 yoy
$0.00
Q3 2026N/M FY25 yoy
$46.32M
Q3 2026+4.7% FY25 yoy
$781.77M
—
1.7×
4.8×
-2.04%
—

Twelve months to Sep 30, 2026 · derived

Price

$3.1149.31%$3.03past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$407.32MFY 2025
$407.32M0FY 2013FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$407,320,000reported
FY 20242024-12-31$333,615,000reported
FY 20232023-12-31$124,456,000reported
FY 20222022-12-31$52,158,000reported
FY 20212021-12-31$10,097,000reported
FY 20202020-12-31$7,571,000reported
FY 20192019-12-31$5,281,000reported
FY 20182018-12-31$2,607,000reported
FY 20172017-12-31$42,000,000reported
FY 20152015-12-31$24,026,000reported
FY 20142014-12-31$31,623,000reported
FY 20132013-12-31$28,928,000reported

Capital returns

Dividends and buybacks · FY2012 to FY2014
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2014—$2.00K$2.00K—18.60M sh+1,417.6%0.0%
FY2013—$2.00K$2.00K—1.23M sh—0.1%
FY2012—$20.00K$20.00K———0.1%

Segments

Revenue by Geography, FY2018 to FY2025FY2018Asia Pacific · FY2018 · $287.00KNorth America · FY2018 · $2.32MFY2019Asia Pacific · FY2019 · $5.28MChina · FY2019 · $3.00MHong Kong · FY2019 · $1.50MJapan · FY2019 · $800.00KFY2020Asia Pacific · FY2020 · $6.77MNorth America · FY2020 · $806.00KNorth America · FY2020 · $806.00KFY2021Asia Pacific · FY2021 · $10.08MNorth America · FY2021 · $13.00KNorth America · FY2021 · $13.00KFY2022United States · FY2022 · $15.60MAsia Pacific · FY2022 · $31.00KNorth America · FY2022 · $36.53MNorth America · FY2022 · $31.00KFY2023United States · FY2023 · $83.28MAsia Pacific · FY2023 · $41.12MNorth America · FY2023 · $59.00KFY2024United States · FY2024 · $319.20MAsia Pacific · FY2024 · $14.34MNorth America · FY2024 · $78.00KFY2025United States · FY2025 · $377.81MAsia Pacific · FY2025 · $29.17MNorth America · FY2025 · $342.00K
LineFY2025ShareChange
United States$377.81M93%+18.4%
Asia Pacific$29.17M7.2%+103.4%
North America$342.00K0.1%+338.5%
China———
Hong Kong———
Japan———
North America———
Total$407.32M

From the 10-K filed Feb 19, 2026ARDX

Pharmaceutical preparations

Ardelyx, Inc. is the 61st largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Ardelyx, Inc. · CIK 1437402 · Engraved from SEC EDGAR